Skip to main content
Premium Trial:

Request an Annual Quote

Applied Proteomics, DKFZ to Collaborate on Cancer MDx

NEW YORK (GenomeWeb News) – Applied Proteomics today said that it will collaborate with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) on the discovery and development of molecular diagnostic tests for colon and pancreatic cancer.

Applied Proteomics President and CEO Peter Klemm said that the firm will leverage its mass spectrometry-based platform in the collaboration. Further terms were not provided by the partners.

San Diego-based Applied Proteomics noted that it is developing a blood-based test for precursors to colorectal cancer aimed at identifying high-risk patients for colonoscopy. The firm recently raised $28 million in a Series C financing round.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.